Citation Impact
Citing Papers
Multi-Institutional Randomized Phase II Trial of Gefitinib for Previously Treated Patients With Advanced Non–Small-Cell Lung Cancer
2003 Standout
Metastasis: from dissemination to organ-specific colonization
2009 Standout
Molecular mechanisms mediating metastasis of hypoxic breast cancer cells
2012 StandoutNobel
Hallmarks of Cancer: The Next Generation
2011 Standout
Multinational Study of the Efficacy and Safety of Humanized Anti-HER2 Monoclonal Antibody in Women Who Have HER2-Overexpressing Metastatic Breast Cancer That Has Progressed After Chemotherapy for Metastatic Disease
1999 Standout
Survival Effect of Maximal Cytoreductive Surgery for Advanced Ovarian Carcinoma During the Platinum Era: A Meta-Analysis
2002 Standout
A randomized, multicenter study to determine the safety and efficacy of the immunoconjugate SGN-15 plus docetaxel for the treatment of non-small cell lung carcinoma
2006
Growth Dominance of the Metastatic Cancer Cell: Cellular and Molecular Aspects
1990
Second-line platinum therapy in patients with ovarian cancer previously treated with cisplatin.
1991 Standout
Cisplatin: mode of cytotoxic action and molecular basis of resistance
2003 Standout
Anti-tumor effect of intraperitoneal administration of cisplatin-loaded microspheres to human tumor xenografted nude mice
2002 StandoutNobel
Twenty‐five years of clinical research for patients with limited‐stage small cell lung carcinoma in North America
2002
Epidermal growth factor receptor mutations in lung cancer
2007 Standout
Cyclophosphamide and Cisplatin Compared with Paclitaxel and Cisplatin in Patients with Stage III and Stage IV Ovarian Cancer
1996 Standout
A cell initiating human acute myeloid leukaemia after transplantation into SCID mice
1994 StandoutNature
Docetaxel (Taxotere) shows survival and quality-of-life benefits in the second-line treatment of non-small cell lung cancer: A review of two phase III trials
2001
Cushing's syndrome
2015 Standout
Structure and physical map of 64 variable segments in the 3′ 0.8–megabase region of the human immunoglobulin heavy–chain locus
1993 StandoutNobel
Genetic instabilities in human cancers
1998 StandoutNature
Gestational trophoblastic disease
2010 Standout
Paclitaxel (Taxol)
1995 Standout
Anthracyclines: Molecular Advances and Pharmacologic Developments in Antitumor Activity and Cardiotoxicity
2004 Standout
Chemotherapy can prolong survival in patients with advanced non-small-cell lung cancer--report of a Canadian multicenter randomized trial.
1988
Clinical applications of quinone-containing alkylating agents
2000
Transluminal Placement of Endovascular Stent-Grafts for the Treatment of Descending Thoracic Aortic Aneurysms
1994 Standout
Psychometric Validation of the Eortc Core Quality of Life Questionnaire, 30-Item Version and A Diagnosis-Specific Module for Head and Neck Cancer Patients
1992
Molecular mechanisms of cisplatin resistance
2011 Standout
Exploiting tumour hypoxia in cancer treatment
2004 Standout
Treatment of advanced epithelial ovarian cancer with cisplatin and cyclophosphamide
1989
A randomized study of radiation treatment in small cell bronchial carcinoma treated with two types of four-drug chemotherapy regimens
1988
Assessment of dose-intensive therapy in suboptimally debulked ovarian cancer: a Gynecologic Oncology Group study.
1995
Molecular and cytogenetic analysis of chromosomal arms 2q and 13q in alveolar rhabdomyosarcoma
1991
Results with the EMA/CO (etoposide, methotrexate, actinomycin D, cyclophosphamide, vincristine) regimen in high risk gestational trophoblastic tumours, 1979 to 1989
1991
Importance of timing for thoracic irradiation in the combined modality treatment of limited-stage small-cell lung cancer. The National Cancer Institute of Canada Clinical Trials Group.
1993 Standout
Reduction by Granulocyte Colony-Stimulating Factor of Fever and Neutropenia Induced by Chemotherapy in Patients with Small-Cell Lung Cancer
1991 Standout
Phase II trial of paclitaxel in patients with progressive ovarian carcinoma after platinum-based chemotherapy: a Gynecologic Oncology Group study.
1994
Emerging Biological Principles of Metastasis
2017 Standout
Congestive heart failure in patients treated with doxorubicin
2003 Standout
Primary vs. secondary neoplasia-associated chromosomal abnormalities—balanced rearrangements vs. genomic imbalances?
1996
Microenvironmental regulation of metastasis
2008 Standout
Strategies and challenges for the next generation of antibody–drug conjugates
2017 Standout
Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation
1991 Standout
The repertoire of human germline vH sequences reveals about fifty groups of VH segments with different hypervariable loops
1992 StandoutNobel
Structural repertoire of the human VH segments
1992 StandoutNobel
Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms
2013 Standout
Use of Chemotherapy plus a Monoclonal Antibody against HER2 for Metastatic Breast Cancer That Overexpresses HER2
2001 Standout
Tumor Hypoxia: Definitions and Current Clinical, Biologic, and Molecular Aspects
2001 Standout
High-dose cisplatin combination chemotherapy in the treatment of advanced epithelial ovarian carcinoma.
1990
Late Cardiac Effects of Doxorubicin Therapy for Acute Lymphoblastic Leukemia in Childhood
1991 Standout
Randomized prospective trial of 5 versus 10 cycles of cyclophosphamide, doxorubicin, and cisplatin in advanced ovarian carcinoma
1992
Comparison of Four Chemotherapy Regimens for Advanced Non–Small-Cell Lung Cancer
2002 Standout
The Ewing Family of Tumors -- A Subgroup of Small-Round-Cell Tumors Defined by Specific Chimeric Transcripts
1994 Standout
The effect of prolonged cisplatin-based chemotherapy on progression-free survival in patients with optimal epithelial ovarian cancer: “Maintenance” therapy reconsidered
1992
Doxorubicin-Induced Cardiomyopathy
1998 Standout
The NCI60 human tumour cell line anticancer drug screen
2006 Standout
Treatment of Philadelphia‐chromosome‐positive human leukemia in scid mouse model with herbimycin A, bcr‐abl tyrosine kinase activity inhibitor
1995 StandoutNobel
Underrepresentation of Patients 65 Years of Age or Older in Cancer-Treatment Trials
1999 Standout
Cancer of the Ovary
2004 Standout
Clinical pharmacology of intraperitoneal cisplatin
1985
The role of clonal selection in the pathogenesis of an autoreactive human B cell lymphoma.
1991
Co-trimoxazole prophylaxis during high-dose chemotherapy of small-cell lung cancer.
1985
Establishment of continuous, clonable cultures of small-cell carcinoma of lung which have amine precursor uptake and decarboxylation cell properties.
1980
Long-term results of a cisplatin-containing combination chemotherapy regimen for the treatment of advanced ovarian carcinoma.
1986
Prevention of High-Dose Chemotherapy–Induced Cardiotoxicity in High-Risk Patients by Angiotensin-Converting Enzyme Inhibition
2006 Standout
Natural History of Arteriosclerotic Thoracic Aortic Aneurysms
1978
Antitumor Antibiotics: Bleomycin, Enediynes, and Mitomycin
2005 Standout
Early anthracycline cardiotoxicity
1978
Ovarian cancer: new clinical approaches
1991
Tumor Cell-Organ Microenvironment Interactions in the Pathogenesis of Cancer Metastasis
2007
Ectopic adrenocorticotrophic (ACTH) syndrome and small cell carcinoma of the lung—assessment of clinical implications in patients on combination chemotherapy
1981
Advanced Ovarian Cancer: Long-Term Results of Treatment with Intensive Cisplatin-Based Chemotherapy of Brief Duration
1988
Risk Factors for Doxorubicin-lnduced Congestive Heart Failure
1979 Standout
Microenvironment-induced cancer metastasis
2000
Chemotherapy with or without Radiation Therapy in Limited Small-Cell Carcinoma of the Lung
1987
AACR Centennial Series: The Biology of Cancer Metastasis: Historical Perspective
2010
Cisplatin combination chemotherapy versus chlorambucil in advanced ovarian carcinoma: mature results of a randomized trial.
1985
A Model of Human Acute Lymphoblastic Leukemia in Immune-Deficient SCID Mice
1989 Science
Cancer Genome Landscapes
2013 StandoutScience
Intraperitoneal Cisplatin and Paclitaxel in Ovarian Cancer
2006 Standout
Quality of Life in Head and Neck Cancer Patients: Validation of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-H&N35
1999 Standout
Chemotherapy Alone or Chemotherapy with Chest Radiation Therapy in Limited Stage Small Cell Lung Cancer
1987
Early Detection of Anthracycline Cardiotoxicity and Improvement With Heart Failure Therapy
2015 Standout
The Anthracycline Antineoplastic Drugs
1981 Standout
Randomized trial of radiotherapy to the thorax in limited small-cell carcinoma of the lung treated with multiagent chemotherapy and elective brain irradiation: a preliminary report.
1984
Ovarian cancer in the elderly: An analysis of Surveillance, Epidemiology, and End Results Program data
1986
A randomized trial of cyclophosphamide and doxorubicin with or without cisplatin in advanced ovarian carcinoma. A gynecologic oncology group study
1986
Overexpression of a Transporter Gene in a Multidrug-Resistant Human Lung Cancer Cell Line
1992 StandoutScience
Works of Greco Fa being referenced
Tumor products and potential markers in small cell lung cancer.
1978
Subclinical adriamycin cardiotoxicity: detection by timing the arterial sounds.
1978
Noninvasive monitoring of adriamycin cardiotoxicity by "Sphygmo-Recording" of the pulse wave delay (QKd interval).
1976
Phase II trial of diaziquone in anthracycline-resistant adult soft tissue and bone sarcoma patients: a Southeastern Cancer Study Group Trial.
1986
Small cell lung cancer: progress and perspectives.
1978
Advanced ovarian cancer: brief intensive combination chemotherapy and second-look operation.
1981
Localized dissecting aneurysm of the aorta: a clinicopathological study.
1975
Complications of treatment of small cell carcinoma of the lung.
1983
Resistant gestational choriocarcinoma: successful treatment with vinblastine, bleomycin, and cisplatin (VBP).
1983
Rationale for chemotherapy for patients with advanced non-small-cell lung cancer.
1986
Cyclophosphamide, doxorubicin, and etoposide as first-line therapy in the treatment of small-cell lung cancer.
1986
Chromosomal and molecular clues to tumor progression.
1989
Multidisciplinary approach to potentially curable non-small cell carcinoma of the lung.
1997
Cyclophosphamide, doxorubicin, and cisplatin in the treatment of advanced non-small cell lung cancer.
1982